FOP is characterized by painful, recurrent episodes of soft tissue swelling (flare-ups) and new abnormal bone formation. The process called heterotopic ossification (HO) occurs in muscles, tendons and
Enhanze is based on a recombinant human hyaluronidase enzyme (rHuPH20) that temporarily modifies hyaluronan, a component of the extracellular matrix, to aid in the dispersion and absorption of
Apotex has been jointly developing the product in collaboration with Intas Pharmaceuticals. The company’s application was filed under the 351(k) abbreviated approval pathway created by the q2Biosimilar Price
The IND covers the company’s clinical development plan for a patented formulation of itraconazole (SUBA-Itraconazole) with improved bioavailability to study the treatment of basal cell carcinoma (BCC) in
As part of the partnership, both the firms will jointly evaluate both clinical and pre-clinical stage projects that will be identified and presented by BioLineRx through a Joint
As part of this collaboration, Ossianix’s new single Blood Brain Barrier (BBB) targeting domain antibody platform that is based on the shark VNAR structure will be used for
The trial is designed to evaluate the safety, tolerability and efficacy of PF-06252616 in boys aged six to less than ten years old diagnosed with DMD regardless of
As part of the deal, the two parties will jointly carry out the clinical proof of concept (PoC) trial of E6201, a dual-targeted FLT3 and MEK inhibitor for
As part of the deal, DURECT will receive an upfront fee of $2m in cash from Santen as well as reverie contingent cash payments upon the achievement of
Following approval, rIX-FP will provide people with hemophilia B and their physicians a long-acting treatment option with dosing intervals up to 14 days. The BLA is based on
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.